Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 400
Summary
- Conditions
- Intraocular Lens Replacement
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01579565
- Collaborators
- Not Provided
- Investigators
- Study Director: Steve Whitaker, MD Omeros Corporation
Get Well Soon